Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7301
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    82.77
    -0.04 (-0.05%)
     
  • Bitcoin CAD

    88,189.22
    -3,013.23 (-3.30%)
     
  • CMC Crypto 200

    1,389.35
    -34.75 (-2.44%)
     
  • GOLD FUTURES

    2,320.70
    -17.70 (-0.76%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,462.00
    -202.50 (-1.15%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     
  • CAD/EUR

    0.6817
    -0.0002 (-0.03%)
     

Better Gene Sequencing Stock: Illumina vs. Bionano Genomics

Better Gene Sequencing Stock: Illumina vs. Bionano Genomics

Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the market and still has a lot to prove to its investors as well as the scientific community, Illumina is the top dog that's fighting to maintain its position. Bulls argue that Illumina is the better gene sequencing stock because in some sequencing markets, it's basically the only option in town, particularly in the all-important market for next generation sequencers (NGS).